微信小陈
微信小章| 产品名称： | Actinomyces israelii (Kruse) Lachner-Sandoval |
|---|---|
| 商品货号： | TS143132 |
| Strain Designations： | 277 CDC W855 |
| Isolation： | Human brain abscess, Rochester, MN |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Serotype 1 |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | no |
| Type Strain： | yes |
| Comments： | Fa-serotyping and physiology |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Anaerobic |
| Name of Depositor： | A Howell |
| Chain of Custody： | ATCC |
| References： | Brock DW, Georg LK. Characterization of Actinomyces israelii serotypes 1 and 2. J. Bacteriol. 97: 589-593, 1969. PubMed: 4886287 Brock DW, Georg LK. Determination and analysis of Actinomyces israelii serotypes by fluorescent-antibody procedures. J. Bacteriol. 97: 581-588, 1969. PubMed: 4886286 Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Slack JM, Gerencser MA. Proposal and description of ATCC 13683 and TS143132 as neotype strains of Actinomyces bovis Harz 1877 and Actinomycess israelii (Kruse) Lachner-Sandoval 1898, respectively. Int. J. Syst. Bacteriol. 26: 85-87, 1976. Thompson L, Lovestedt SA. An actinomyces-like organism obtained from the human mouth. Proc. Staff Meet. Mayo Clin. 26: 169-175, 1951. Thompson L. Isolation and comparison of Actionmyces from human and bovine infections. Proc. Staff Meet. Mayo Clin. 25: 81-86, 1950. |
| Cross References： | Nucleotide (GenBank) : AF058042 Actinomyces israelii strain TS143132 16S ribosomal RNA gene, partial sequence. |